(Q32129064)

6 July 2017

1 reference

title

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management (English)

1 reference

6 July 2017

0 references

1 reference

cognitive dysfunction

1 reference

Bridget Bagert

1

1 reference

6 July 2017

Patricia Camplair

series ordinal

2

1 reference

6 July 2017

Dennis Bourdette

series ordinal

3

1 reference

6 July 2017

1 January 2002

1 reference

6 July 2017

1 reference

6 July 2017

16

1 reference

6 July 2017

7

1 reference

6 July 2017

445-455

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200216070-00002

6 July 2017

0 references

cites work

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadi

1 reference

12 December 2020

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

1 reference

12 December 2020

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

1 reference

12 December 2020

Cognition in patients with multiple sclerosis After four years.

1 reference

12 December 2020

Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning

1 reference

12 December 2020

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

12 December 2020

Neuropsychological aspects of multiple sclerosis.

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis.

1 reference

12 December 2020

MRI correlates of cognitive dysfunction in multiple sclerosis patients.

1 reference

12 December 2020

Fatigue in Multiple Sclerosis

1 reference

12 December 2020

The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up.

1 reference

12 December 2020

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

1 reference

12 December 2020

A study of performance of delayed intentions in multiple sclerosis.

1 reference

12 December 2020

Memory impairment in multiple sclerosis: a quantitative review

1 reference

12 December 2020

The nature of memory impairments in multiple sclerosis: acquisition versus retrieval.

1 reference

12 December 2020

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

1 reference

12 December 2020

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up

1 reference

12 December 2020

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

1 reference

12 December 2020

Cognitive therapy for multiple sclerosis: a preliminary study.

1 reference

12 December 2020

Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.

1 reference

12 December 2020

The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, multiple sclerosis, and depression

1 reference

12 December 2020

Screening for cognitive dysfunction in multiple sclerosis

1 reference

12 December 2020

Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study

1 reference

12 December 2020

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

1 reference

12 December 2020

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

12 December 2020

Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.

1 reference

12 December 2020

Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis

1 reference

12 December 2020

Affective disorders in multiple sclerosis. Review and recommendations for clinical research

1 reference

12 December 2020

Memory impairment in multiple sclerosis.

1 reference

12 December 2020

Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

1 reference

12 December 2020

Cognitive and physical fatigue in multiple sclerosis: relations between self-report and objective performance

1 reference

12 December 2020

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

1 reference

12 December 2020

On the nature of memory disturbance in multiple sclerosis.

1 reference

12 December 2020

Effects of neuropsychological treatment in patients with multiple sclerosis.

1 reference

12 December 2020

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

1 reference

12 December 2020

Neuropsychology of multiple sclerosis

1 reference

12 December 2020

Learning impairment is associated with recall ability in multiple sclerosis.

1 reference

12 December 2020

Neuropsychological deficits in multiple sclerosis after acute relapse

1 reference

12 December 2020

Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis.

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Assessing the prevalence of cognitive impairment in multiple sclerosis: implications for patient management

1 reference

12 December 2020

Acquisition and storage deficits in multiple sclerosis.

1 reference

12 December 2020

Neuropsychological aspects of multiple sclerosis: a quantitative review

1 reference

12 December 2020

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

12 December 2020

Neuropsychology of multiple sclerosis: a critical review

1 reference

12 December 2020

Information processing efficiency in patients with multiple sclerosis.

1 reference

12 December 2020

The influence of cognitive impairment on driving performance in multiple sclerosis

1 reference

12 December 2020

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

1 reference

12 December 2020

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

1 reference

12 December 2020

MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Cortical lesions in multiple sclerosis

1 reference

12 December 2020

Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination.

1 reference

12 December 2020

Computer assisted retraining of attentional impairments in patients with multiple sclerosis

1 reference

12 December 2020

Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning

1 reference

12 December 2020

10.2165/00023210-200216070-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference